Results for randomiziranih translation from Slovenian to English

n randomiziranih bolnikov
n randomised

lastnosti randomiziranih bolnikov
features of randomized patients

n število randomiziranih bolnikov.
n number of patients randomised

n = število randomiziranih preiskovancev
n = number of subjects randomised

infliksimab združeni Število randomiziranih
infliximab subjects randomized

878 bolnikov je bilo randomiziranih v dve skupini.
878 patients were randomised to the two arms.

ta skupina je predstavljala 21% randomiziranih bolnikov.
the great majority of diabetes cases came from the subgroup of patients with impaired glucose tolerance at baseline, which represented 21% of the randomised patients.

povprečna starost randomiziranih preiskovancev je bila 49,1 leta.
mean age of subjects randomized was 49.1 years.

preglednica 2: rezultati učinkovitosti v randomiziranih kliničnih študijah
table 2: efficacy results in randomized clinical studies

randomiziranih je bilo skupno 1.106 bolnikov, 553 na vsak krak.
a total of 1,106 patients were randomised, 553 to each arm.

delež randomiziranih bolnikov z indukcijo remisije po 12 mesecih zdravljenja
proportion of randomized patients with induction of remission after 12 months of treatment

v vseh randomiziranih skupinah so uporabili kratkodelujoči agonist β2 po potrebi.
all treatment arms used a short-acting β2 adrenoceptor agonist as needed.

v randomiziranih kliničnih preskušanjih so uporabljali subkutani odmerek 23 x 106i. e.
the choice of route should depend on the individual clinical circumstance.

od 278 randomiziranih bolnikov je 277 bolnikov prejelo vsaj 1 odmerek raziskovanega zdravila.
of the 278 patients randomised, 277 patients received at least 1 dose of study drug.

n = število randomiziranih bolnikov, ki so prejeli vsaj 1 odmerek preiskovanega zdravila
n = randomised patients who received at least 1 dose of study medication

v randomiziranih kliničnih preskušanjih z zdravilom regranex so poročali o naslednjih neželenih reakcijah:
the following adverse reactions were reported in the randomised clinical trials of regranex therapy:

učinkovitost in varnost zdravila eurartesim so preskušali v dveh velikih odprtih randomiziranih kliničnih preskušanjih.
the efficacy and safety of eurartesim have been assessed in two large randomised, open-label clinical trials:

# skupno je bilo randomiziranih 154 bolnikov (s stanjem zmogljivosti po ecog 0 ali 1).
# a total of 154 patients (ecog performance status 0 or 1) were randomized.

v spodnje skupine zdravljenja je bilo randomiziranih skupno 1006 bolnikov z zmogljivostjo po karnofskem ≥ 60:
a total of 1006 patients with kps ≥ 60 were randomized to the following treatment groups:

60 bolnikov je bilo randomiziranih in zdravljenih in 60/60 (100 %) jih je doseglo srv12.
60 patients were randomized and treated, and 60/60 (100%) achieved svr12.